HomePVCT • OTCMKTS
add
Provectus Biopharmaceuticals Inc
Previous close
$0.090
Day range
$0.090 - $0.098
Year range
$0.045 - $0.22
Market cap
41.02M USD
Avg Volume
265.98K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 254.99K | 57.56% |
Operating expense | 448.93K | 15.48% |
Net income | -846.85K | -1.41% |
Net profit margin | -332.11 | 35.63% |
Earnings per share | — | — |
EBITDA | -646.66K | -1.92% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 29.58K | -83.19% |
Total assets | 856.43K | -49.22% |
Total liabilities | 8.37M | -6.83% |
Total equity | -7.51M | — |
Shares outstanding | 419.91M | — |
Price to book | -4.50 | — |
Return on assets | -167.64% | — |
Return on capital | 37.21% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -846.85K | -1.41% |
Cash from operations | -762.58K | -23.44% |
Cash from investing | — | — |
Cash from financing | 588.95K | -10.28% |
Net change in cash | -173.47K | -560.08% |
Free cash flow | -232.85K | -10.22% |
About
Founded
2002
Headquarters
Website
Employees
4
